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INTRODUCTION
Small Amyloid beta (A␤) oligomers and protofibrills are currently regarded as crucial factors for neurodegeneration in Alzheimer's disease (AD) (Klein, 2001) . The accumulation of toxic, oligomeric A␤ is roughly concomitant with the onset of behavioral abnormalities (Kawarabayashi, 2001) in transgenic "AD" animals. Conversely, the decrease in the whole brain load of A␤ by immunization improves the behavioral impairment in A␤ overexpressing mice (Janus, 2000) .
Moreover, A␤-40 and A␤-42 are elevated early in dementia and their concentrations strongly correlate with cognitive decline in humans (Naslund, 2000) . Asides from senile plaques and neurofibrillary tangles, activated microglial cells and astrocytes are constant pathological features of AD. These cells do not only sustain the normal function of neurons, but can also produce inflammatory compounds such as complement components, enzymes and cytokines (McGeer, 1995) . The involvement of the non-specific innate immune system in the development of AD has also been indirectly documented in several epidemiological studies, which demonstrate an inverse relationship between the intake of nonsteroidal anti-inflam-
